Prot# 0001A3-300-GL: Phase 3 Open-Label Randomized Study of Amonafide L-Malate in Combination with Cytarabine Compared to Daunorubicin in Combination with Cytarabine in Patients with Secondary Acute Myeloid Leukemia (AML)

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/2/08 → 12/1/11

Funding

  • Xanthus Life Sciences, Inc. (0001A3-300-GL)